CHMP Announces Positive Opinion for REZOLSTA™, a New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir and Cobicistat
CHMP also issues two label extensions for darunavir
- 29.09.2014, 12:29
- Kategoria: Zdrowie i styl życia
- Źródło: PR Newswire